{
    "Trade/Device Name(s)": [
        "BD MAX Enteric Parasite Control Panel",
        "BD MAX Enteric Parasite 20-Day QC Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K181711",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "June 27, 2018",
    "Summary Letter Received Date": "June 28, 2018",
    "Submission Date": "August 6, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "parisitology"
    ],
    "Analyte(s)": [
        "Cryptosporidium parvum",
        "Giardia lamblia",
        "Entamoeba histolytica"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Micro-centrifuge tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing procedures"
    ],
    "Methodologies": [
        "Extraction",
        "Amplification",
        "Detection"
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX Enteric Parasite Control and QC Panels for monitoring nucleic acid testing performance of enteric parasite detection on the BD MAX System",
    "Indications for Use Summary": "Intended as external assayed positive quality control materials to monitor in vitro nucleic acid testing procedures for qualitative detection of Cryptosporidium parvum, Giardia lamblia, and Entamoeba histolytica with the BD MAX Enteric Parasite Panel on the BD MAX System",
    "fda_folder": "Microbiology"
}